Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - ArriVent BioPharma, Inc. Common Stock | StockGist | StockGist

Companies
AVBP
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings AVBPSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

ArriVent BioPharma, Inc. Common Stock

Filed Oct 30, 2025

Accepted Oct 29, 2025, 8:00 PM ET

CIK 0001868279

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

ArriVent BioPharma, Inc.

Person Type

IA

CUSIP: 04272N102

Amendment History

6 filings

SCHEDULE 13G
Original
Viewing
Oct 30, 20250000102909-25-000025
SCHEDULE 13G/A
Amendment 1
Aug 13, 20250000919574-25-004712
SCHEDULE 13G/A
Amendment 2
Aug 14, 20250001415889-25-021943
SCHEDULE 13G/A
Amendment 3
Oct 17, 20250002012383-25-002500
SCHEDULE 13G/A
Amendment 4
Nov 5, 20250000315066-25-002677
SCHEDULE 13G/A
Amendment 5
Latest
Nov 14, 20250001214659-25-016716

Recent Filings

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice